On July 18, 2025, Abeona Therapeutics Inc. entered into an amendment to its loan agreement, reducing the interest rate from 13.5% to 11.75%. The company also issued warrants to purchase up to 16,474 shares at an exercise price of $6.07, expiring on July 18, 2030.